These findings highlight a critical and growing public health challenge: more Americans are learning about GLP-1 medications by chance on unregulated social media feeds than seeking information from medical professionals, said Sherry Emery, a senior fellow in NORCs Public Health department
Cardiovascular Outcomes Liraglutide (LEADER trial): 13% reduction in major adverse cardiovascular events (MACE) in patients with Type 2 diabetes and high cardiovascular risk Statistically significant cardiovascular protection Semaglutide (SELECT trial): 20% reduction in MACE in patients with obesity and established cardiovascular disease Studied specifically for cardiovascular outcomes in obesity (not just diabetes) Both medications provide cardiovascular protection, but semaglutides evidence is more recent, more robust, and specifically applicable to patients with obesity regardless of diabetes status
Glutathione as a skin-lightening agent: Facts, myths, evidence and controversies
Taken together, nutritional management during GLP-1RA therapy may be viewed as stabilization of substrate-sensitive metabolic control nodes operating under chronic flux constriction
Cracks in the glass, a loose or damaged stopper, or any sign that the seal has been compromised means the vial is no longer sterile
Eat more sulfur-rich foods like garlic and cruciferous vegetables and make sure you get enough selenium